# Neuraltus Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/neuraltus-pharmaceuticals

- Industry: Biotechnology
- Headquarters: Palo Alto, US
- Website: www.neuraltus.com
- Total disclosed funding: $15M
- Latest round: Series B (Jan 31, 2012)
- Investors on record: 3

## About

Neuraltus Pharmaceuticals, Inc. is based in US and operates as a biopharmaceutical firm.

## Funding rounds

- Series B, Jan 31, 2012, $9.6M — Adams Street Partners, Latterell Venture Partners, VantagePoint Capital
- Series D, Mar 25, 2009, $4.9M — Adams Street Partners, Latterell Venture Partners, VantagePoint Capital

## Investors

- Adams Street Partners (https://capitalatlas.ai/funds/adams-street-partners) — Series D, Series B
- Latterell Venture Partners (https://capitalatlas.ai/funds/latterell-venture-partners) — Series D, Series B
- VantagePoint Capital (https://capitalatlas.ai/funds/vantagepoint-capital) — Series D, Series B